Literature DB >> 6186899

Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.

H Geyer, S Schlecht, K Himmelspach.   

Abstract

Oligosaccharide subunits from Klebsiella pneumoniae B5055 capsular polysaccharide, covalently linked to protein carriers, the native polysaccharide, and killed whole bacteria, were compared with respect to their immunogenicity in mice and their capacity to protect mice against bacterial infection. The protection was studied (a) by active immunization and (b) by passive administration of antisera raised in rabbits using the different immunogens. The results were as follows: in the active protection experiments the octa- and dodecasaccharide conjugates were as effective as the polysaccharide in increasing the LD50 by a factor of 10(5) as compared to nonimmunized animals. Thus, these antigens were only slightly less effective than killed bacteria. In contrast the tetrasaccharide conjugate was at least 1000-fold less effective than all other antigens used. In the passive protection experiments these results were paralleled in that the antiserum against the tetrasaccharide conjugate also showed the lowest degree of protection, though, for methodical reasons, the differences in the LD50s were less pronounced. The drastically lower efficiency of the tetrasaccharide in comparision to its higher oligomers is in agreement with serological findings previously published (see first communication), which showed that two repeating units are the minimum requirement for a substantial representation of polysaccharide serological specificity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6186899     DOI: 10.1007/bf02123621

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  18 in total

1.  Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide.

Authors:  B A BATSHON; H BAER; M F SHAFFER
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

2.  Carbohydrate antigens: coupling fo oligosaccharide-phenethylamine derivatives to edestin by diazotization and characterization of antibody specificity by radioimmunoassay.

Authors:  D A Zopf; C M Tsai; V GOINSBURG
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2 specificity. I. Specificity and crossreactivity of anti-conjugate versus anti-bacterial antibodies.

Authors:  H Geyer; S Stirm; K Himmelspach
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

4.  Antibodies to carbohydrates: preparation of antigens by coupling carbohydrates to proteins by reductive amination with cyanoborohydride.

Authors:  G R Gray
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

5.  Sensitivity of passive haemagglutination for assay of 7S and 19S antibodies in primary rabbit anti-bovine serum albumin sera.

Authors:  A A Benedict
Journal:  Nature       Date:  1965-06-26       Impact factor: 49.962

6.  Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.

Authors:  S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.

Authors:  S B Svenson; M Nurminen; A A Lindberg
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

8.  [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].

Authors:  S Schlecht; O Westphal
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-10

9.  PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES.

Authors:  C M Macleod; R G Hodges; M Heidelberger; W G Bernhard
Journal:  J Exp Med       Date:  1945-11-30       Impact factor: 14.307

10.  ANTIBODY FORMATION IN VOLUNTEERS FOLLOWING INJECTION OF PNEUMOCOCCI OR THEIR TYPE-SPECIFIC POLYSACCHARIDES.

Authors:  M Heidelberger; C M Macleod; S J Kaiser; B Robinson
Journal:  J Exp Med       Date:  1946-03-31       Impact factor: 14.307

View more
  3 in total

1.  Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.

Authors:  J W Zigterman; J E van Dam; H Snippe; F T Rotteveel; M Jansze; J M Willers; J P Kamerling; J F Vliegenthart
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

2.  Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use.

Authors:  I-Fan Tu; Tzu-Lung Lin; Feng-Ling Yang; I-Ming Lee; Wei-Lin Tu; Jiahn-Haur Liao; Tzu-Ping Ko; Wen-Jin Wu; Jia-Tsrong Jan; Meng-Ru Ho; Ching-Yi Chou; Andrew H-J Wang; Chung-Yi Wu; Jin-Town Wang; Kai-Fa Huang; Shih-Hsiung Wu
Journal:  J Biomed Sci       Date:  2022-02-07       Impact factor: 8.410

3.  LPS O Antigen Plays a Key Role in Klebsiella pneumoniae Capsule Retention.

Authors:  Shweta Singh; Jonathan J Wilksch; Rhys A Dunstan; Anna Mularski; Nancy Wang; Dianna Hocking; Leila Jebeli; Hanwei Cao; Abigail Clements; Adam W J Jenney; Trevor Lithgow; Richard A Strugnell
Journal:  Microbiol Spectr       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.